Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 21, 2019; 25(39): 6025-6040
Published online Oct 21, 2019. doi: 10.3748/wjg.v25.i39.6025
Published online Oct 21, 2019. doi: 10.3748/wjg.v25.i39.6025
Comparison | Healing rate (%) | Heterogeneity | OR | 95%CI | P value | ||
Allicin group | Control | I2 (%) | P value | ||||
Allicin + PTT vs PTT[15-18,20] (ITT) | 80.32 | 68.29 | 0 | 0.527 | 2.14 | 1.39-3.29 | 0.001 |
Allicin + PTT vs PTT[15-18,20] (PP) | 80.65 | 68.57 | 0 | 0.513 | 1.93 | 1.25-2.96 | 0.003 |
Allicin-PPI-B-T-C vs PPI-B-T-C[21,22] (ITT/PP) | 95.51 | 87.82 | 22.924 | 0.255 | 2.83 | 1.13-7.10 | 0.026 |
Allicin-PPI-Am-F vs PPI-Am-F[15,18,20] (ITT/PP) | 83.62 | 65.00 | 0 | 0.660 | 1.90 | 1.18-3.06 | 0.002 |
- Citation: Si XB, Zhang XM, Wang S, Lan Y, Zhang S, Huo LY. Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis. World J Gastroenterol 2019; 25(39): 6025-6040
- URL: https://www.wjgnet.com/1007-9327/full/v25/i39/6025.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i39.6025